Loading insider details...
Latest Form 4 (Jun 5, 2026): Grant/Award of 35,500 ABOS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 5, 2026 | Acumen Pharmaceuticals, Inc. (ABOS) | Grant/Award | 35,500 | n/a |
| Jun 2, 2026 | Taysha Gene Therapies, Inc. (TSHA) | Grant/Award | 21,335 | n/a |
| Jun 5, 2025 | Acumen Pharmaceuticals, Inc. (ABOS) | Grant/Award | 12,800 | n/a |
| Jun 4, 2025 | Taysha Gene Therapies, Inc. (TSHA) | Grant/Award | 56,623 | n/a |
| Nov 26, 2024 | Verrica Pharmaceuticals Inc. (VRCA) | Purchase | 1,123,595 | n/a |
| Jun 10, 2024 | Acumen Pharmaceuticals, Inc. (ABOS) | Grant/Award | 25,000 | n/a |
| May 31, 2024 | Taysha Gene Therapies, Inc. (TSHA) | Grant/Award | 49,220 | n/a |
| Aug 17, 2023 | Taysha Gene Therapies, Inc. (TSHA) | Purchase | 388,889 | $350.0K |
| Jun 26, 2023 | Taysha Gene Therapies, Inc. (TSHA) | Grant/Award | 43,800 | n/a |
| Jun 7, 2023 | Acumen Pharmaceuticals, Inc. (ABOS) | Grant/Award | 25,000 | n/a |